ACADIA Pharmaceuticals, Inc. (ACAD)

22.16 -0.24 (-1.07%) USD  |  NASDAQ  |  Mar 06, 16:00
22.17 +0.01 (+0.05%) After-Hours: 20:00
More

ACADIA Pharmaceuticals CAPEX To Revenue (TTM)

CAPEX To Revenue (TTM) Chart

View CAPEX To Revenue (TTM) for ACAD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View CAPEX To Revenue (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

CAPEX To Revenue (TTM) Range, Past 5 Years

View CAPEX To Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

CAPEX To Revenue (TTM) Benchmarks

View CAPEX To Revenue (TTM) Benchmarks
Start Trial
Insmed, Inc. Upgrade
Madrigal Pharmaceuticals, Inc. Upgrade
Marker Therapeutics, Inc. Upgrade
Agilent Technologies, Inc. Upgrade
BioMarin Pharmaceutical, Inc. Upgrade